Researchers are studying how tumors evolve and develop resistance to therapy, with a focus on understanding the biological mechanisms behind this resistance. Various studies are examining tumor heterogeneity, genomic evolution, and single-cell transcriptomics in different types of cancer, including pancreatic, breast, and non-small cell lung cancer. The goal of this research appears to be to identify ways to overcome therapeutic resistance and develop more effective treatment strategies.